Evidence map›Paper›PMID 34126308›Full record

Trial reportJournal of affective disorders2021

Multilevel growth curve analyses of behavioral activation for anhedonia (BATA) and mindfulness-based cognitive therapy effects on anhedonia and resting-state functional connectivity: Interim results of a randomized trial

Paul Cernasov, Erin C Walsh, Jessica L Kinard, Lisalynn Kelley, Rachel Phillips, Angela Pisoni, Tory A Eisenlohr-Moul, Macey Arnold, Sarah C Lowery, Marcy Ammirato and 6 more

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of affective disorders, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Not Feeling It: Modifiable Correlates of Anhedonia.Behavioral sciences (Basel, Switzerland) · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Behavioral Activation and Brain Network Changes in Depression.Journal of clinical neurology (Seoul, Korea) · 2024
    Review
  15. A Review of Transdiagnostic Mechanisms in Cognitive Behavior Therapy.The Psychiatric clinics of North America · 2024
    Review
  16. Article
  17. Article
  18. Article
  19. Psychological Treatments for Anhedonia.Current topics in behavioral neurosciences · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Paul CernasovDepartment of Psychology and Neuroscience, University of North Carolina-Chapel Hill, Chapel Hill, NC 27514, USA.
Erin C WalshDepartment of Psychiatry, University of North Carolina-Chapel Hill, Chapel Hill, NC 57514, USA.
Jessica L KinardCarolina Institute for Developmental Disabilities, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27510, USA; Division of Speech and Hearing Sciences, University of North Carolina-Chapel Hill, Chapel Hill, NC 27514, USA.
Lisalynn KelleyDepartment of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27705, USA.
Rachel PhillipsDepartment of Psychology and Neuroscience, University of North Carolina-Chapel Hill, Chapel Hill, NC 27514, USA.
Angela PisoniDepartment of Psychology and Neuroscience, Duke University, Durham, NC 27505, USA.
Tory A Eisenlohr-MoulDepartment of Psychiatry, University of Illinois at Chicago, Neuropsychiatry Institute, Chicago, IL 60612, USA.
Macey ArnoldDepartment of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27705, USA.
Sarah C LoweryDepartment of Psychology and Neuroscience, University of North Carolina-Chapel Hill, Chapel Hill, NC 27514, USA.
Marcy AmmiratoDepartment of Psychology and Neuroscience, University of North Carolina-Chapel Hill, Chapel Hill, NC 27514, USA.
Kinh TruongDepartment of Biostatistics, University of North Carolina-Chapel Hill, Chapel Hill, NC, 27514, USA.
Gabriela A NagyDepartment of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27705, USA; Duke University School of Nursing, 307 Trent Drive, Durham, NC 27710, USA.
Jason A OliverDepartment of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27705, USA; Division of Cancer Control and Population Sciences, Duke Cancer Institute, Durham, NC 27705, USA.
Kevin HaworthDepartment of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27705, USA.
Moria SmoskiDepartment of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27705, USA; Department of Psychology and Neuroscience, Duke University, Durham, NC 27505, USA.
Gabriel S DichterDepartment of Psychology and Neuroscience, University of North Carolina-Chapel Hill, Chapel Hill, NC 27514, USA; Department of Psychiatry, University of North Carolina-Chapel Hill, Chapel Hill, NC 57514, USA; Carolina Institute for Developmental Disabilities, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27510, USA. Electronic address: dichter@med.unc.edu.
University of North Carolina at Chapel Hill · USDuke University · USUniversity of Illinois Chicago · US

Funding

Re-Entry Supplement: Investigation of Oral Microbial Enzymes for the Detection and Treatment of Periodontal DiseaseUL1TR002489 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSE, JOHN BERNARD, SHAHEEN, NICHOLAS J · 2018 to 2022
$48.6M
North Carolina Translational and Clinical Science Institute (NC TraCS) KL2KL2TR002490 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WEINBERGER, MORRIS · 2018 to 2022
$11.0M
Preclinical CoreP50HD103573 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Mark D Shen · 2020 to 2026
$9.7M
Development of A Novel Transdiagnostic Intervention for AnhedoniaR33MH110027 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DICHTER, GABRIEL S, SMOSKI, MORIA J. · 2019 to 2021
$2.3M
Development of A Novel Transdiagnostic Intervention for AnhedoniaR61MH110027 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DICHTER, GABRIEL S, SMOSKI, MORIA J. · 2017 to 2018
$1.9M
Neuroinflammatory Mechanisms of Anhedonia in Major DepressionK23MH113733 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WALSH, ERIN · 2018 to 2023
$866k
Nicotine Withdrawal and Reward Processing: Connecting Neurobiology toReal-World BehaviorK23DA042898 · NIDA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI OLIVER, JASON ANTHONY · 2017 to 2021
$855k
Evaluating State-Based Network Dynamics in AnhedoniaF31MH120900 · NIMH · DUKE UNIVERSITY · PI PISONI, ANGELA · 2020 to 2022
$118k
NCATS NIH HHS KL2 TR002490NCATS NIH HHS UL1 TR002489NICHD NIH HHS P50 HD103573NIDA NIH HHS K23 DA042898NIMH NIH HHS F31 MH120900NIMH NIH HHS K23 MH113733NIMH NIH HHS L30 MH120618NIMH NIH HHS R33 MH110027NIMH NIH HHS R61 MH110027
6 · The paper itself

Abstract

backgroundThe neural mechanisms associated with anhedonia treatment response are poorly understood. Additionally, no study has investigated changes in resting-state functional connectivity (rsFC) accompanying psychosocial treatment for anhedonia.

methodsWe evaluated a novel psychotherapy, Behavioral Activation Therapy for Anhedonia (BATA, n = 38) relative to Mindfulness-Based Cognitive Therapy (MBCT, n = 35) in a medication-free, transdiagnostic, anhedonic sample in a parallel randomized controlled trial. Participants completed up to 15 sessions of therapy and up to four 7T MRI scans before, during, and after treatment (n = 185 scans). Growth curve models estimated change over time in anhedonia and in rsFC using average region-of-interest (ROI)-to-ROI connectivity within the default mode network (DMN), frontoparietal network (FPN), salience network, and reward network. Changes in rsFC from pre- to post-treatment were further evaluated using whole-network seed-to-voxel and ROI-to-ROI edgewise analyses.

resultsGrowth curve models showed significant reductions in anhedonia symptoms and in average rsFC within the DMN and FPN over time, across BATA and MBCT. There were no differences in anhedonia reductions between treatments. Within-person, changes in average rsFC were unrelated to changes in anhedonia. Between-person, higher than average FPN rsFC was related to less anhedonia across timepoints. Seed-to-voxel and edgewise rsFC analyses corroborated reductions within the DMN and between the DMN and FPN over time, across the sample.

conclusionsReductions in rsFC within the DMN, FPN, and between these networks co-occurred with anhedonia improvement across two psychosocial treatments for anhedonia. Future anhedonia clinical trials with a waitlist control group should disambiguate treatment versus time-related effects on rsFC.

Indexed as

Cognitive Behavioral TherapyMindfulnessAnhedoniaBrainBrain MappingHumansMagnetic Resonance ImagingAnhedoniafMRIRDoCResting state connectivityTransdiagnostic

Identifiers

PMID34126308
PMCPMC8282772
OpenAlexW3171729910

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.